Bain Capital Public Equity Management Ii, LLC Novo Nordisk A S Transaction History

Bain Capital Public Equity Management Ii, LLC

$2.08 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $17.8 Million - $23.3 Million	-359,574 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $17.9 Million - $20.9 Million	359,574 New	359,574 $20.8 Million

Others Institutions Holding NVO

# of Institutions

1,961

Shares Held

320M

Call Options Held

5.16M

Put Options Held

4.96M

Jennison Associates LLC

21.2M
Shares

$2.33 Billion
1.95% of portfolio
Morgan Stanley New York, NY

14.6M
Shares

$1.6 Billion
0.16% of portfolio
Bank Of America Corp Charlotte, NC

14.2M
Shares

$1.56 Billion
0.18% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.4M
Shares

$1.47 Billion
0.83% of portfolio
Fayez Sarofim & CO Houston, TX

12.6M
Shares

$1.38 Billion
4.91% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $248B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account